Vi Fund Opportunities Science Life Puissance Net Worth & Insider Trades
Vi Fund Opportunities Science Life Puissance Tracon Pharmaceuticals, Inc
What is Vi Fund Opportunities Science Life Puissance's Net Worth?
The current estimated net worth of Tracon Pharmaceuticals, Inc's Vi Fund Opportunities Science Life Puissance is estimated to be about $15.38M . Vi Fund Opportunities Science Life Puissance owns about 9,203,536 units of Tracon Pharmaceuticals, Inc common stock. Recently at Tracon Pharmaceuticals, Inc, Vi Fund Opportunities Science Life Puissance has sold an estimated value of $0 worth.
What is Vi Fund Opportunities Science Life Puissance's Past Insider Trading?
Vi Fund Opportunities Science Life Puissance's largest purchase order was 8,652 units , worth over $10.12K on December 3, 2018. In total, Vi Fund Opportunities Science Life Puissance has made about 1 transaction recently at Tracon Pharmaceuticals, Inc. Vi Fund Opportunities Science Life Puissance usually trades in December, with the busiest year in 2018.
Puissance CrossBorder Opportunities V LLC, Puissance CrossBorder Opportunities IV LLC, VI Fund Opportunities Science Life Puissance, Puissance Capital Management LP, Puissance Capital Management GP LLC, Puissance Capital Fund GP LLC, Theodore Wang
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Vi Fund Opportunities Science Life Puissance's' Mailing Address?
- Mailing address is 950 Third Avenue FL 25 New York NY 10022 NY
What are Tracon Pharmaceuticals, Inc's Past Insider Trades?
Tracon Pharmaceuticals, Inc's most recent insider trade came on March 13, 2023 by Opaleye Management Inc who bought 174,508 units worth $240.82K . In the last 8 years, insiders at Tracon Pharmaceuticals, Inc have sold an estimated value of $5.32M and bought an estimated value of $151.37M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Charles Theuer, President and CEO, Opaleye Management Inc, and Partnership Limited Investment Super Jafco V .
Tracon Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||